Skip to main content
Top
Published in: Orphanet Journal of Rare Diseases 1/2012

Open Access 01-12-2012 | Research

A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study

Authors: Paola Pierucci, Gennaro M Lenato, Patrizia Suppressa, Patrizia Lastella, Vincenzo Triggiani, Raffaella Valerio, Mario Comelli, Daniela Salvante, Alessandro Stella, Nicoletta Resta, Giancarlo Logroscino, Francesco Resta, Carlo Sabbà

Published in: Orphanet Journal of Rare Diseases | Issue 1/2012

Login to get access

Abstract

Background

The difficulty in establishing a timely correct diagnosis is a relevant matter of concern for several rare diseases. Many rare-disease-affected patients suffer from considerable diagnostic delay, mainly due to their poor knowledge among healthcare professionals, insufficient disease awareness among patients’ families, and lack of promptly available diagnostic tools. Hereditary Haemorrhagic Telangiectasia (HHT) is an autosomal-dominantly inherited vascular dysplasia, affecting 1:5,000-10,000 patients. HHT is characterized by high variability of clinical manifestations, which show remarkable overlapping with several common diseases.

Aim

To perform a detailed analysis concerning the diagnostic time lag occurring in patients with HHT, defined as the time period spanning from the first clinical manifestation to the attainment of a definite, correct diagnosis.

Methods

A questionnaire was administered to the HHT patients previously recruited from 2000 and 2009. Clinical onset, first referral to a physician for disease manifestations, and first correct diagnosis of definite HHT were collected. Eventual misdiagnosis at first referral and serious complications occurring throughout the time elapsing between disease onset and definite diagnosis were also addressed.

Results

In the 233 respondents, the clinical onset of disease occurred at an age of 14.1 yrs, while the age of first referral and the age of first definite diagnosis of HHT were 29.2 yrs and 40.1 yrs, respectively. Only 88/233 patients received a correct diagnosis at first counseling. Thus, the diagnostic time lag, represented by the time elapsing from disease onset and first definite diagnosis of HHT, proved to be 25.7 yrs. Twenty-two patients suffered from severe complications during this time interval. The diagnostic delay was significantly longer (p < 0.001) in index patients (first patients who attained definite HHT diagnosis in a given family) than in non-index patients (relative of index patients). The diagnostic time lag was also significantly associated with education grade (p < 0.001).

Conclusions

Our data report for the first time a systematic inquiry of diagnostic delay in HHT showing that patients receive a definite diagnosis only after nearly three decades from disease onset. Concerted efforts are still to be made to increase awareness of this disease among both families and physicians.
Appendix
Available only for authorised users
Literature
1.
go back to reference Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A: Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat. 2002, 19: 140-148. 10.1002/humu.10026.CrossRefPubMed Dakeishi M, Shioya T, Wada Y, Shindo T, Otaka K, Manabe M, Nozaki J, Inoue S, Koizumi A: Genetic epidemiology of hereditary hemorrhagic telangiectasia in a local community in the northern part of Japan. Hum Mutat. 2002, 19: 140-148. 10.1002/humu.10026.CrossRefPubMed
2.
go back to reference Begbie ME, Wallace GM, Shovlin CL: Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J. 2003, 79: 18-24. 10.1136/pmj.79.927.18.PubMedCentralCrossRefPubMed Begbie ME, Wallace GM, Shovlin CL: Hereditary haemorrhagic telangiectasia (Osler-Weber-Rendu syndrome): a view from the 21st century. Postgrad Med J. 2003, 79: 18-24. 10.1136/pmj.79.927.18.PubMedCentralCrossRefPubMed
3.
4.
go back to reference Shovlin CL: Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010, 24: 203-219. 10.1016/j.blre.2010.07.001.CrossRefPubMed Shovlin CL: Hereditary haemorrhagic telangiectasia: pathophysiology, diagnosis and treatment. Blood Rev. 2010, 24: 203-219. 10.1016/j.blre.2010.07.001.CrossRefPubMed
5.
go back to reference Cole SG, Begbie ME, Wallace GM, Shovlin CL: A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005, 42: 577-582. 10.1136/jmg.2004.028712.PubMedCentralCrossRefPubMed Cole SG, Begbie ME, Wallace GM, Shovlin CL: A new locus for hereditary haemorrhagic telangiectasia (HHT3) maps to chromosome 5. J Med Genet. 2005, 42: 577-582. 10.1136/jmg.2004.028712.PubMedCentralCrossRefPubMed
6.
go back to reference Bayrak-Toydemir P, Mao R, Lewin S, McDonald J: Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Genet Med. 2004, 6: 175-191. 10.1097/01.GIM.0000132689.25644.7C.CrossRefPubMed Bayrak-Toydemir P, Mao R, Lewin S, McDonald J: Hereditary hemorrhagic telangiectasia: an overview of diagnosis and management in the molecular era for clinicians. Genet Med. 2004, 6: 175-191. 10.1097/01.GIM.0000132689.25644.7C.CrossRefPubMed
7.
go back to reference Sekarski LA, Spangenberg LA: Hereditary hemorrhagic telangiectasia: children need screening too. Pediatr Nurs. 2011, 37: 163-168.PubMed Sekarski LA, Spangenberg LA: Hereditary hemorrhagic telangiectasia: children need screening too. Pediatr Nurs. 2011, 37: 163-168.PubMed
8.
go back to reference Gattorno M, La Regina M, Martini A, Manna R: An update on autoinflammatory diseases. New concepts for new and old diseases. Clin Exp Rheumatol. 2009, 27: 354-365.PubMed Gattorno M, La Regina M, Martini A, Manna R: An update on autoinflammatory diseases. New concepts for new and old diseases. Clin Exp Rheumatol. 2009, 27: 354-365.PubMed
9.
go back to reference Shook SJ, Pioro EP: Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient. Ann Neurol. 2009, 65 (Suppl 1): s10-s16.CrossRefPubMed Shook SJ, Pioro EP: Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient. Ann Neurol. 2009, 65 (Suppl 1): s10-s16.CrossRefPubMed
10.
go back to reference Campos MA, Alazami S, Zhang G, Salathe M, Wanner A, Sandhaus RA, Baier H: Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years. Chest. 2009, 135: 600-608. 10.1378/chest.08-1129.CrossRefPubMed Campos MA, Alazami S, Zhang G, Salathe M, Wanner A, Sandhaus RA, Baier H: Clinical characteristics of subjects with symptoms of alpha1-antitrypsin deficiency older than 60 years. Chest. 2009, 135: 600-608. 10.1378/chest.08-1129.CrossRefPubMed
11.
go back to reference Pol K, Jarosz M: Relapsing polychondritis: case report and literature review. Pol Arch Med Wewn. 2009, 119: 680-683.PubMed Pol K, Jarosz M: Relapsing polychondritis: case report and literature review. Pol Arch Med Wewn. 2009, 119: 680-683.PubMed
13.
go back to reference Lenato GM, Lastella P, Di Giacomo MC, Resta N, Suppressa P, Pasculli G, Sabbà C, Guanti G: DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population. Hum Mutat. 2006, 27: 213-214.CrossRefPubMed Lenato GM, Lastella P, Di Giacomo MC, Resta N, Suppressa P, Pasculli G, Sabbà C, Guanti G: DHPLC-based mutation analysis of ENG and ALK-1 genes in HHT Italian population. Hum Mutat. 2006, 27: 213-214.CrossRefPubMed
14.
go back to reference Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H: Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000, 6: 66-67.CrossRef Shovlin CL, Guttmacher AE, Buscarini E, Faughnan ME, Hyland RH, Westermann CJ, Kjeldsen AD, Plauchu H: Diagnostic criteria for hereditary hemorrhagic telangiectasia (Rendu-Osler-Weber syndrome). Am J Med Genet. 2000, 6: 66-67.CrossRef
15.
go back to reference Sabbà C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, Dicuonzo F, Guanti G: Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost. 2007, 5: 1149-1157. 10.1111/j.1538-7836.2007.02531.x.CrossRefPubMed Sabbà C, Pasculli G, Lenato GM, Suppressa P, Lastella P, Memeo M, Dicuonzo F, Guanti G: Hereditary hemorrhagic telangiectasia: clinical features in ENG and ALK1 mutation carriers. J Thromb Haemost. 2007, 5: 1149-1157. 10.1111/j.1538-7836.2007.02531.x.CrossRefPubMed
16.
go back to reference R Development Core Team: R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; ISBN 3- 900051-07-0[http://www.R-project.org]. R Development Core Team: R: A language and environment for statistical computing. Vienna, Austria: R Foundation for Statistical Computing; ISBN 3- 900051-07-0[http://​www.​R-project.​org].
17.
go back to reference Guttmacher AE, Marchuk DA, White RI: Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995, 5: 918-924.CrossRef Guttmacher AE, Marchuk DA, White RI: Hereditary hemorrhagic telangiectasia. N Engl J Med. 1995, 5: 918-924.CrossRef
18.
go back to reference Sabbà C: A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia. J Thromb Haemost. 2005, 3: 2201-2210. 10.1111/j.1538-7836.2005.01345.x.CrossRefPubMed Sabbà C: A rare and misdiagnosed bleeding disorder: hereditary hemorrhagic telangiectasia. J Thromb Haemost. 2005, 3: 2201-2210. 10.1111/j.1538-7836.2005.01345.x.CrossRefPubMed
19.
go back to reference Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, et al: International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011, 48: 73-87. 10.1136/jmg.2009.069013.CrossRefPubMed Faughnan ME, Palda VA, Garcia-Tsao G, Geisthoff UW, McDonald J, Proctor DD, Spears J, Brown DH, Buscarini E, Chesnutt MS, Cottin V, Ganguly A, Gossage JR, Guttmacher AE, Hyland RH, Kennedy SJ, Korzenik J, Mager JJ, Ozanne AP, Piccirillo JF, Picus D, Plauchu H, Porteous ME, Pyeritz RE, Ross DA, Sabba C, Swanson K, Terry P, Wallace MC, Westermann CJ, et al: International guidelines for the diagnosis and management of hereditary haemorrhagic telangiectasia. J Med Genet. 2011, 48: 73-87. 10.1136/jmg.2009.069013.CrossRefPubMed
20.
go back to reference Cohen JH, Faughnan ME, Letarte M, Vandezande K, Kennedy SJ, Krahn MD: Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Am J Med Genet A. 2005, 30: 153-160.CrossRef Cohen JH, Faughnan ME, Letarte M, Vandezande K, Kennedy SJ, Krahn MD: Cost comparison of genetic and clinical screening in families with hereditary hemorrhagic telangiectasia. Am J Med Genet A. 2005, 30: 153-160.CrossRef
21.
go back to reference Pasculli G, Sallustio G, Sabbà C: The need for an interdisciplinary network of investigations on HHT. Curr Pharm Des. 2006, 12: 1249-1251. 10.2174/138161206776361327.CrossRefPubMed Pasculli G, Sallustio G, Sabbà C: The need for an interdisciplinary network of investigations on HHT. Curr Pharm Des. 2006, 12: 1249-1251. 10.2174/138161206776361327.CrossRefPubMed
22.
go back to reference Folz BJ, Zoll B, Alfke H, Toussaint A, Maier RF, Werner JA: Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents. Eur Arch Otorhinolaryngol. 2006, 263: 53-61. 10.1007/s00405-005-0956-8.CrossRefPubMed Folz BJ, Zoll B, Alfke H, Toussaint A, Maier RF, Werner JA: Manifestations of hereditary hemorrhagic telangiectasia in children and adolescents. Eur Arch Otorhinolaryngol. 2006, 263: 53-61. 10.1007/s00405-005-0956-8.CrossRefPubMed
23.
go back to reference Cirulli A, Liso A, D'Ovidio F, Mestice A, Pasculli G, Gallitelli M, Rizzi R, Specchia G, Sabbà C: Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Haematol. 2003, 110: 29-32. 10.1159/000072411.CrossRefPubMed Cirulli A, Liso A, D'Ovidio F, Mestice A, Pasculli G, Gallitelli M, Rizzi R, Specchia G, Sabbà C: Vascular endothelial growth factor serum levels are elevated in patients with hereditary hemorrhagic telangiectasia. Acta Haematol. 2003, 110: 29-32. 10.1159/000072411.CrossRefPubMed
24.
go back to reference Sadick H, Riedel F, Naim R, Goessler U, Hörmann K, Hafner M, Lux A: Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Haematologica. 2005, 90: 818-828.PubMed Sadick H, Riedel F, Naim R, Goessler U, Hörmann K, Hafner M, Lux A: Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Haematologica. 2005, 90: 818-828.PubMed
25.
go back to reference Giordano P, Lenato GM, Pierucci P, Suppressa P, Altomare M, Del Vecchio G, Di Bitonto G, De Mattia D, Guanti G, Sabbà C: Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia. J Pediatr Hematol Oncol. 2009, 31: 577-582. 10.1097/MPH.0b013e3181a1c104.CrossRefPubMed Giordano P, Lenato GM, Pierucci P, Suppressa P, Altomare M, Del Vecchio G, Di Bitonto G, De Mattia D, Guanti G, Sabbà C: Effects of VEGF on phenotypic severity in children with hereditary hemorrhagic telangiectasia. J Pediatr Hematol Oncol. 2009, 31: 577-582. 10.1097/MPH.0b013e3181a1c104.CrossRefPubMed
26.
go back to reference Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI Jr, Dunn J, Letarte M: Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res. 2000, 47: 24-35. 10.1203/00006450-200001000-00008.CrossRefPubMed Cymerman U, Vera S, Pece-Barbara N, Bourdeau A, White RI Jr, Dunn J, Letarte M: Identification of hereditary hemorrhagic telangiectasia type 1 in newborns by protein expression and mutation analysis of endoglin. Pediatr Res. 2000, 47: 24-35. 10.1203/00006450-200001000-00008.CrossRefPubMed
27.
go back to reference Sanz-Rodriguez F, Fernandez-L A, Zarrabeitia R, Perez-Molino A, Ramírez JR, Coto E, Bernabeu C, Botella LM: Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes. Clin Chem. 2004, 50: 2003-2011. 10.1373/clinchem.2004.035287.CrossRefPubMed Sanz-Rodriguez F, Fernandez-L A, Zarrabeitia R, Perez-Molino A, Ramírez JR, Coto E, Bernabeu C, Botella LM: Mutation analysis in Spanish patients with hereditary hemorrhagic telangiectasia: deficient endoglin up-regulation in activated monocytes. Clin Chem. 2004, 50: 2003-2011. 10.1373/clinchem.2004.035287.CrossRefPubMed
28.
go back to reference Ojeda-Fernandez L, Barrios L, Rodriguez-Barbero A, Recio-Poveda L, Bernabeu C, Botella LM: Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT). Clin Chim Acta. 2010, 20: 411494-411499. Ojeda-Fernandez L, Barrios L, Rodriguez-Barbero A, Recio-Poveda L, Bernabeu C, Botella LM: Reduced plasma levels of Ang-2 and sEng as novel biomarkers in hereditary hemorrhagic telangiectasia (HHT). Clin Chim Acta. 2010, 20: 411494-411499.
29.
go back to reference Bernhardt BA, Zayac C, Pyeritz RE: Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia. Genet Med. 2011, 13: 812-820. 10.1097/GIM.0b013e31821d2e6d.PubMedCentralCrossRefPubMed Bernhardt BA, Zayac C, Pyeritz RE: Why is genetic screening for autosomal dominant disorders underused in families? The case of hereditary hemorrhagic telangiectasia. Genet Med. 2011, 13: 812-820. 10.1097/GIM.0b013e31821d2e6d.PubMedCentralCrossRefPubMed
30.
go back to reference Fernandez-Lopez A, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Morales C, Restrepo CM, Ramirez JR, Coto E, Lenato GM, Bernabeu C, Botella LM: Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia and expression analysis of Endoglin and ALK1. Hum Mutat. 2006, 27: 295.CrossRef Fernandez-Lopez A, Sanz-Rodriguez F, Zarrabeitia R, Perez-Molino A, Morales C, Restrepo CM, Ramirez JR, Coto E, Lenato GM, Bernabeu C, Botella LM: Mutation study of Spanish patients with Hereditary Hemorrhagic Telangiectasia and expression analysis of Endoglin and ALK1. Hum Mutat. 2006, 27: 295.CrossRef
31.
go back to reference McDonald JE, Miller FJ, Hallam SE, Nelson L, Marchuk DA, Ward KJ: Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet. 2000, 93: 320-327. 10.1002/1096-8628(20000814)93:4<320::AID-AJMG12>3.0.CO;2-R.CrossRefPubMed McDonald JE, Miller FJ, Hallam SE, Nelson L, Marchuk DA, Ward KJ: Clinical manifestations in a large hereditary hemorrhagic telangiectasia (HHT) type 2 kindred. Am J Med Genet. 2000, 93: 320-327. 10.1002/1096-8628(20000814)93:4<320::AID-AJMG12>3.0.CO;2-R.CrossRefPubMed
33.
go back to reference Aron DC: Cushing's syndrome: why is diagnosis so difficult?. Rev Endocr Metab Disord. 2010, 11: 105-116. 10.1007/s11154-010-9127-3.CrossRefPubMed Aron DC: Cushing's syndrome: why is diagnosis so difficult?. Rev Endocr Metab Disord. 2010, 11: 105-116. 10.1007/s11154-010-9127-3.CrossRefPubMed
34.
go back to reference De P, Evans LM, Scanlon MF, Davies JS: "Osler's phenomenon": misdiagnosing Cushing's syndrome. Postgrad Med J. 2003, 79: 594-596. 10.1136/pmj.79.936.594.PubMedCentralCrossRefPubMed De P, Evans LM, Scanlon MF, Davies JS: "Osler's phenomenon": misdiagnosing Cushing's syndrome. Postgrad Med J. 2003, 79: 594-596. 10.1136/pmj.79.936.594.PubMedCentralCrossRefPubMed
Metadata
Title
A long diagnostic delay in patients with Hereditary Haemorrhagic Telangiectasia: a questionnaire-based retrospective study
Authors
Paola Pierucci
Gennaro M Lenato
Patrizia Suppressa
Patrizia Lastella
Vincenzo Triggiani
Raffaella Valerio
Mario Comelli
Daniela Salvante
Alessandro Stella
Nicoletta Resta
Giancarlo Logroscino
Francesco Resta
Carlo Sabbà
Publication date
01-12-2012
Publisher
BioMed Central
Published in
Orphanet Journal of Rare Diseases / Issue 1/2012
Electronic ISSN: 1750-1172
DOI
https://doi.org/10.1186/1750-1172-7-33

Other articles of this Issue 1/2012

Orphanet Journal of Rare Diseases 1/2012 Go to the issue